Multiple interests in structural models of DARC transmembrane protein;Multiples intérêts des modèles structuraux de la protéine transmembranaire Darc

Transfusion Clinique et Biologique

Volumn 17, Issue 3, 2010, Pages 184-196

  Smolarek, D ^a,b,c,d   Bertrand, O ^a,b,c   Czerwinski, M ^d   Colin, Y ^a,b,c   Etchebest, C ^a,b,c   de Brevern, A G ^a,b,c  

^a hôpital Robert Debré et Institut national de la transfusion sanguine   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^d INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Bioinformatics; Camelid VHHs; Cancer; Comparative modelling; Flexible docking; Malaria; Protein docking; Transmembrane protein

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; DUFFY ANTIGEN RECEPTOR FOR CHEMOKINE; DUFFY BINDING PROTEIN; ERYTHROCYTE MEMBRANE PROTEIN 1; INTERLEUKIN 8; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BIOINFORMATICS; BLOOD GROUP DUFFY SYSTEM; COMPUTER PROGRAM; CONSENSUS SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; MALARIA; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PLASMODIUM VIVAX; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN STRUCTURE; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 77955851414     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2010.05.003     Document Type: Short Survey

References (153)

1. Cutbush M., Mollison P.L. The Duffy blood group system. Heredity 1950, 4:383-389.
2. Ikin E.W., Mourant A.E., Pettenkofer H.J., Blumenthal G. Discovery of the expected haemagglutinin, anti-Fyb. Nature 1951, 168:1077-1078.
3. Sanger R., Race R.R., Jack J. The Duffy blood groups of New York negroes: the phenotype Fy (a-b-). Br J Haematol 1955, 1:370-374.
4. de Brevern A.G., Wong H., Tournamille C., Colin Y., Le Van Kim C., Etchebest C. A structural model of a seven-transmembrane helix receptor: the Duffy antigen/receptor for chemokine (DARC). Biochim Biophys Acta 2005, 1724:288-306.
5. de Brevern A.G., Autin L., Colin Y., Bertrand O., Etchebest C. In silico studies on DARC. Infect Disord Drug Targets 2009, 9:289-303.
6. Smolarek D, Hattab C, Hassanzadeh-Ghassabeh G, Cochet S, Gutiérrez C, de Brevern AG, et al. A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy Antigen Receptor for Chemokines. Cell Mol Life Sci (in press).
7. Hadley T.J., Peiper S.C. From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. Blood 1997, 89:3077-3091.
8. Tournamille C., Le Van Kim C., Gane P., Cartron J.P., Colin Y. Molecular basis and PCR-DNA typing of the Fya/fyb blood group polymorphism. Hum Genet 1995, 95:407-410.
9. Tournamille C., Filipe A., Wasniowska K., Gane P., Lisowska E., Cartron J.P., et al. Structure-function analysis of the extracellular domains of the Duffy antigen/receptor for chemokines: characterization of antibody and chemokine binding sites. Br J Haematol 2003, 122:1014-1023.
10. Tournamille C., Colin Y., Cartron J.P., Le Van Kim C. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 1995, 10:224-228.
11. Peiper S.C., Wang Z.X., Neote K., Martin A.W., Showell H.J., Conklyn M.J., et al. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med 1995, 181:1311-1317.
12. Horuk R., Martin A., Hesselgesser J., Hadley T., Lu Z.H., Wang Z.X., et al. The Duffy antigen receptor for chemokines: structural analysis and expression in the brain. J Leukoc Biol 1996, 59:29-38.
13. Miller L.H., Mason S.J., Dvorak J.A., McGinniss M.H., Rothman I.K. Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants. Science 1975, 189:561-563.
14. Miller L.H., Mason S.J., Clyde D.F., McGinniss M.H. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med 1976, 295:302-304.
15. Zimmerman P.A., Woolley I., Masinde G.L., Miller S.M., McNamara D.T., Hazlett F., et al. Emergence of FY*A(null) in a Plasmodium vivax-endemic region of Papua New Guinea. Proc Natl Acad Sci U S A 1999, 96:13973-13977.
16. Chootong P., Ntumngia F.B., VanBuskirk K.M., Xainli J., Cole-Tobian J.L., Campbell C.O., et al. Mapping epitopes of the Plasmodium vivax Duffy binding protein with naturally acquired inhibitory antibodies. Infect Immun 2010, 78:1089-1095.
17. Rowe J.A., Opi D.H., Williams T.N. Blood groups and malaria: fresh insights into pathogenesis and identification of targets for intervention. Curr Opin Hematol 2009, 16:480-487.
18. King C.L., Michon P., Shakri A.R., Marcotty A., Stanisic D., Zimmerman P.A., et al. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection. Proc Natl Acad Sci U S A 2008, 105:8363-8368.
19. Souza-Silva F.A., da Silva-Nunes M., Sanchez B.A., Ceravolo I.P., Malafronte R.S., Brito C.F., et al. Naturally acquired antibodies to Plasmodium vivax Duffy binding protein (DBP) in Brazilian Amazon. Am J Trop Med Hyg 2010, 82:185-193.
20. Storti-Melo L.M., de Souza-Neiras W.C., Cassiano G.C., Joazeiro A.C., Fontes C.J., Bonini-Domingos C.R., et al. Plasmodium vivax circumsporozoite variants and Duffy blood group genotypes in the Brazilian Amazon region. Trans R Soc Trop Med Hyg 2009, 103:672-678.
21. Ménard D, Barnadas C, Bouchier C, Henry-Halldin C, Gray LR, Ratsimbasoa A, Thonier V, Carod JF, Domarle O, Colin Y, Bertrand O, Picot J, King CL, Grimberg BT, Mercereau-Puijalon O, Zimmerman PA. Plasmodium vivax clinical malaria is commonly observed in Duffy negative Malagasy people. Proc Natl Acad Sci U S A 107:5967-71.
22. Avril M., Hathaway M.J., Cartwright M.M., Gose S.O., Narum D.L., Smith J.D. Optimizing expression of the pregnancy malaria vaccine candidate VAR2CSA in Pichia pastoris. Malar J 2009, 8:143.
23. Mayor A., Rovira-Vallbona E., Srivastava A., Sharma S.K., Pati S.S., Puyol L., et al. Functional and immunological characterization of a Duffy binding-like alpha domain from Plasmodium falciparum erythrocyte membrane protein 1 that mediates rosetting. Infect Immun 2009, 77:3857-3863.
24. Higgins M.K. The structure of a chondroitin sulfate-binding domain important in placental malaria. J Biol Chem 2008, 283:21842-21846.
25. Singh K., Gittis A.G., Nguyen P., Gowda D.C., Miller L.H., Garboczi D.N. Structure of the DBL3x domain of pregnancy-associated malaria protein VAR2CSA complexed with chondroitin sulfate A. Nat Struct Mol Biol 2008, 15:932-938.
26. Singh S.K., Hora R., Belrhali H., Chitnis C.E., Sharma A. Structural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain. Nature 2006, 439:741-744.
27. Tolia N.H., Enemark E.J., Sim B.K., Joshua-Tor L. Structural basis for the EBA-175 erythrocyte invasion pathway of the malaria parasite Plasmodium falciparum. Cell 2005, 122:183-193.
28. Shen H., Schuster R., Stringer K.F., Waltz S.E., Lentsch A.B. The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth. FASEB J 2006, 20:59-64.
29. Pruenster M., Rot A. Throwing light on DARC. Biochem Soc Trans 2006, 34:1005-1008.
30. Rot A. Chemokine patterning by glycosaminoglycans and interceptors. Front Biosci 2010, 15:645-660.
31. Borroni E.M., Bonecchi R., Buracchi C., Savino B., Mantovani A., Locati M. Chemokine decoy receptors: new players in reproductive immunology. Immunol Invest 2008, 37:483-497.
32. Neote K., DiGregorio D., Mak J.Y., Horuk R., Schall T.J. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 1993, 72:415-425.
33. Hadley T.J., Lu Z.H., Wasniowska K., Martin A.W., Peiper S.C., Hesselgesser J., et al. Postcapillary venule endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the Duffy blood group antigen. J Clin Invest 1994, 94:985-991.
34. Neote K., Mak J.Y., Kolakowski L.F., Schall T.J. Functional and biochemical analysis of the cloned Duffy antigen: identity with the red blood cell chemokine receptor. Blood 1994, 84:44-52.
35. Reutershan J., Harry B., Chang D., Bagby G.J., Ley K. DARC on RBC limits lung injury by balancing compartmental distribution of CXC chemokines. Eur J Immunol 2009, 39:1597-1607.
36. Pruenster M., Mudde L., Bombosi P., Dimitrova S., Zsak M., Middleton J., et al. The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nat Immunol 2009, 10:101-108.
37. Smith E., McGettrick H.M., Stone M.A., Shaw J.S., Middleton J., Nash G.B., et al. Duffy antigen receptor for chemokines and CXCL5 are essential for the recruitment of neutrophils in a multicellular model of rheumatoid arthritis synovium. Arthritis Rheum 2008, 58:1968-1973.
38. Zarbock A., Schmolke M., Bockhorn S.G., Scharte M., Buschmann K., Ley K., et al. The Duffy antigen receptor for chemokines in acute renal failure: a facilitator of renal chemokine presentation. Crit Care Med 2007, 35:2156-2163.
39. Chakera A., Seeber R.M., John A.E., Eidne K.A., Greaves D.R. The duffy antigen/receptor for chemokines exists in an oligomeric form in living cells and functionally antagonizes CCR5 signaling through hetero-oligomerization. Mol Pharmacol 2008, 73:1362-1370.
40. Lachgar A., Jaureguiberry G., Le Buenac H., Bizzini B., Zagury J.F., Rappaport J., et al. Binding of HIV-1 to RBCs involves the Duffy antigen receptors for chemokines (DARC). Biomed Pharmacother 1998, 52:436-439.
41. He W., Neil S., Kulkarni H., Wright E., Agan B.K., Marconi V.C., et al. Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility. Cell Host Microbe 2008, 4:52-62.
42. Beck Z., Brown B.K., Wieczorek L., Peachman K.K., Matyas G.R., Polonis V.R., et al. Human erythrocytes selectively bind and enrich infectious HIV-1 virions. PLoS One 2009, 4:e8297.
43. Kulkarni H., Marconi V.C., He W., Landrum M.L., Okulicz J.F., Delmar J., et al. The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry. Blood 2009, 114:2783-2792.
44. Winkler C.A., An P., Johnson R., Nelson G.W., Kirk G. Expression of Duffy antigen receptor for chemokines (DARC) has no effect on HIV-1 acquisition or progression to AIDS in African Americans. Cell Host Microbe 2009, 5:411-413. author reply 8-9.
45. Julg B., Reddy S., van der Stok M., Kulkarni S., Qi Y., Bass S., et al. Lack of Duffy antigen receptor for chemokines: no influence on HIV disease progression in an African treatment-naive population. Cell Host Microbe 2009, 5:413-415. [author reply 8-9].
46. Walley N.M., Julg B., Dickson S.P., Fellay J., Ge D., Walker B.D., et al. The Duffy antigen receptor for chemokines null promoter variant does not influence HIV-1 acquisition or disease progression. Cell Host Microbe 2009, 5:408-410. [author reply 18-9].
47. Horton L.W., Yu Y., Zaja-Milatovic S., Strieter R.M., Richmond A. Opposing roles of murine duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth. Cancer Res 2007, 67:9791-9799.
48. Zerfaoui M., Naura A.S., Errami Y., Hans C.P., Rezk B.M., Park J., et al. Effects of PARP-1 deficiency on airway inflammatory cell recruitment in response to LPS or TNF: differential effects on CXCR2 ligands and Duffy antigen receptor for chemokines. J Leukoc Biol 2009, 86:1385-1392.
49. Lentsch A.B. The Duffy antigen/receptor for chemokines (DARC) and prostate cancer A role as clear as black and white?. FASEB J 2002, 16:1093-1095.
50. Wang J., Ou Z.L., Hou Y.F., Luo J.M., Shen Z.Z., Ding J., et al. Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential. Oncogene 2006, 25:7201-7211.
51. Le Van Kim C., Tournamille C., Kroviarski Y., Cartron J.P., Colin Y. The 1.35-kb and 7.5-kb Duffy mRNA isoforms are differently regulated in various regions of brain, differ by the length of their 5' untranslated sequence, but encode the same polypeptide. Blood 1997, 90:2851-2853.
52. Tournamille C. Molecular basis and structure-activity relationships of the Duffy blood group antigens: chemokine and Plasmodium vivax receptors. Transfus Clin Biol 2000, 7:497-509.
53. Tournamille C., Blancher A., Le Van Kim C., Gane P., Apoil P.A., Nakamoto W., et al. Sequence, evolution and ligand binding properties of mammalian Duffy antigen/receptor for chemokines. Immunogenetics 2004, 55:682-694.
54. Tournamille C., Le Van Kim C., Gane P., Blanchard D., Proudfoot A.E., Cartron J.P., et al. Close association of the first and fourth extracellular domains of the Duffy antigen/receptor for chemokines by a disulfide bond is required for ligand binding. J Biol Chem 1997, 272:16274-16280.
55. Tournamille C., Le Van Kim C., Gane P., Le Pennec P.Y., Roubinet F., Babinet J., et al. Arg89Cys substitution results in very low membrane expression of the Duffy antigen/receptor for chemokines in Fy(x) individuals. Blood 1998, 92:2147-2156.
56. Czerwinski M., Kern J., Grodecka M., Paprocka M., Krop-Watorek A., Wasniowska K. Mutational analysis of the N-glycosylation sites of Duffy antigen/receptor for chemokines. Biochem Biophys Res Commun 2007, 356:816-821.
57. Wasniowska K., Blanchard D., Janvier D., Wang Z.X., Peiper S.C., Hadley T.J., et al. Identification of the Fy6 epitope recognized by two monoclonal antibodies in the N-terminal extracellular portion of the Duffy antigen receptor for chemokines. Mol Immunol 1996, 33:917-923.
58. Sim B.K., Chitnis C.E., Wasniowska K., Hadley T.J., Miller L.H. Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. Science 1994, 264:1941-1944.
59. Tournamille C., Filipe A., Badaut C., Riottot M.M., Longacre S., Cartron J.P., et al. Fine mapping of the Duffy antigen binding site for the Plasmodium vivax Duffy-binding protein. Mol Biochem Parasitol 2005, 144:100-103.
60. de Brevern A.G. New opportunities to fight against infectious diseases and to identify pertinent drug targets with novel methodologies. Infect Disord Drug Targets 2009, 9:246-247.
61. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., et al. The Protein Data Bank. Nucleic Acids Res 2000, 28:235-242.
62. Tusnady G.E., Dosztanyi Z., Simon I. PDB_TM: selection and membrane localization of transmembrane proteins in the protein data bank. Nucleic Acids Res 2005, 33:D275-D278.
63. von Heijne G. Membrane-protein topology. Nat Rev Mol Cell Biol 2006, 7:909-918.
64. McLuskey K., Roszak A.W., Zhu Y., Isaacs N.W. Crystal structures of all-alpha type membrane proteins. Eur Biophys J 2010, 39:723-755.
65. Neumann S., Fuchs A., Mulkidjanian A., Frishman D. Current status of membrane protein structure classification. Proteins 2010, 78:1760-1773.
66. White S.H. The progress of membrane protein structure determination. Protein Sci 2004, 13:1948-1949.
67. White S.H. Biophysical dissection of membrane proteins. Nature 2009, 459:344-346.
68. Newstead S., Ferrandon S., Iwata S. Rationalizing alpha-helical membrane protein crystallization. Protein Sci 2008, 17:466-472.
69. Harrington S.E., Ben-Tal N. Structural determinants of transmembrane helical proteins. Structure 2009, 17:1092-1103.
70. de Brevern AG. 3D-structural models of transmembrane proteins. In: JJL, editor. Membrane protein structure determination: from structure to function. In: Methods in Molecular Biology, collection NJ, USA: Humana Press Inc. (in press).
71. Fernandez-Fuentes N., Madrid-Aliste C.J., Rai B.K., Fajardo J.E., Fiser A. M4T: a comparative protein structure modeling server. Nucleic Acids Res 2007, 35:W363-W368.
72. Kosinski J., Gajda M.J., Cymerman I.A., Kurowski M.A., Pawlowski M., Boniecki M., et al. Frankenstein becomes a cyborg: the automatic recombination and realignment of fold recognition models in CASP6. Proteins. 2005, 61(Suppl.7):106-113.
73. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., et al. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 2000, 289:739-745.
74. Wasniowska K., Petit-LeRoux Y., Tournamille C., Le van Kim C., Cartron J.P., Colin Y., et al. Structural characterization of the epitope recognized by the new anti-Fy6 monoclonal antibody NaM 185-2C3. Transfus Med 2002, 12:205-211.
75. Cserzo M., Wallin E., Simon I., von Heijne G., Elofsson A. Prediction of transmembrane alpha-helices in prokaryotic membrane proteins: the dense alignment surface method. Protein Eng 1997, 10:673-676.
76. von Heijne G. Membrane protein structure prediction. Hydrophobicity analysis and the positive-inside rule. J Mol Biol 1992, 225:487-494.
77. Claros M.G., von Heijne G. TopPred II: an improved software for membrane protein structure predictions. Comput Appl Biosci 1994, 10:685-686.
78. Tusnady G.E., Simon I. Principles governing amino acid composition of integral membrane proteins: application to topology prediction. J Mol Biol 1998, 283:489-506.
79. Tusnady G.E., Simon I. The HMMTOP transmembrane topology prediction server. Bioinformatics 2001, 17:849-850.
80. Krogh A., Larsson B., von Heijne G., Sonnhammer E.L. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 2001, 305:567-580.
81. Rost B., Casadio R., Fariselli P., Sander C. Transmembrane helices predicted at 95% accuracy. Protein Sci 1995, 4:521-533.
82. Rost B., Fariselli P., Casadio R. Topology prediction for helical transmembrane proteins at 86% accuracy. Protein Sci 1996, 5:1704-1718.
83. Hofmann K., Stoffel W. TMbase - a database of membrane spanning proteins segments. Biol Chem Hoppe-Seyler 1993, 374:166-169.
84. Hirokawa T., Boon-Chieng S., Mitaku S. SOSUI: classification and secondary structure prediction system for membrane proteins. Bioinformatics 1998, 14:378-379.
85. Mitaku S., Hirokawa T. Physicochemical factors for discriminating between soluble and membrane proteins: hydrophobicity of helical segments and protein length. Protein Eng 1999, 12:953-957.
86. Mitaku S., Hirokawa T., Tsuji T. Amphiphilicity index of polar amino acids as an aid in the characterization of amino acid preference at membrane-water interfaces. Bioinformatics 2002, 18:608-616.
87. Juretic D., Lee B., Trinajstic N., Williams R.W. Conformational preference functions for predicting helices in membrane proteins. Biopolymers 1993, 33:255-273.
88. Juretic D., Zoranic L., Zucic D. Basic charge clusters and predictions of membrane protein topology. J Chem Inf Comput Sci 2002, 42:620-632.
89. Pasquier C., Hamodrakas S.J. An hierarchical artificial neural network system for the classification of transmembrane proteins. Protein Eng 1999, 12:631-634.
90. Pasquier C., Promponas V.J., Palaios G.A., Hamodrakas J.S., Hamodrakas S.J. A novel method for predicting transmembrane segments in proteins based on a statistical analysis of the SwissProt database: the PRED-TMR algorithm. Protein Eng 1999, 12:381-385.
91. Persson B., Argos P. Prediction of transmembrane segments in proteins utilising multiple sequence alignments. J Mol Biol 1994, 237:182-192.
92. Persson B., Argos P. Topology prediction of membrane proteins. Protein Sci 1996, 5:363-371.
93. Kihara D., Shimizu T., Kanehisa M. Prediction of membrane proteins based on classification of transmembrane segments. Protein Eng 1998, 11:961-970.
94. Deber C.M., Wang C., Liu L.P., Prior A.S., Agrawal S., Muskat B.L., et al. TM Finder: a prediction program for transmembrane protein segments using a combination of hydrophobicity and nonpolar phase helicity scales. Protein Sci 2001, 10:212-219.
95. Zhou H., Zhou Y. Predicting the topology of transmembrane helical proteins using mean burial propensity and a hidden-Markov-model-based method. Protein Sci 2003, 12:1547-1555.
96. Jones D.T., Taylor W.R., Thornton J.M. A model recognition approach to the prediction of all-helical membrane protein structure and topology. Biochemistry 1994, 33:3038-3049.
97. Jones D.T. Do transmembrane protein superfolds exist?. FEBS Lett 1998, 423:281-285.
98. Viklund H., Elofsson A. Best alpha-helical transmembrane protein topology predictions are achieved using hidden Markov models and evolutionary information. Protein Sci 2004, 13:1908-1917.
99. Shen H., Chou J.J. MemBrain: improving the accuracy of predicting transmembrane helices. PLoS ONE 2008, 3:e2399.
100. Cao B., Porollo A., Adamczak R., Jarrell M., Meller J. Enhanced recognition of protein transmembrane domains with prediction-based structural profiles. Bioinformatics 2006, 22:303-309.
101. Jones D.T. Protein secondary structure prediction based on position-specific scoring matrices. J Mol Biol 1999, 292:195-202.
102. Pylouster J., Bornot A., Etchebest C., de Brevern A.G. Influence of assignment on the prediction of transmembrane helices in protein structures. Amino Acids 2010, (in press).
103. Kabsch W., Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 1983, 22:2577-2637.
104. de Brevern A.G., Etchebest C., Hazout S. Bayesian probabilistic approach for predicting backbone structures in terms of protein blocks. Proteins 2000, 41:271-287.
105. Etchebest C., Benros C., Hazout S., de Brevern A.G. A structural alphabet for local protein structures: improved prediction methods. Proteins 2005, 59:810-827.
106. Sali A., Blundell T.L. Definition of general topological equivalence in protein structures. A procedure involving comparison of properties and relationships through simulated annealing and dynamic programming. J Mol Biol 1990, 212:403-428.
107. Sali A., Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 1993, 234:779-815.
108. Marti-Renom M.A., Stuart A.C., Fiser A., Sanchez R., Melo F., Sali A. Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct 2000, 29:291-325.
109. Canutescu A.A., Shelenkov A.A., Dunbrack R.L. A graph-theory algorithm for rapid protein side-chain prediction. Protein Sci 2003, 12:2001-2014.
110. Kutzner C., van der Spoel D., Fechner M., Lindahl E., Schmitt U.W., de Groot B.L., et al. Speeding up parallel GROMACS on high-latency networks. J Comput Chem 2007, 28:2075-2084.
111. Van Der Spoel D., Lindahl E., Hess B., Groenhof G., Mark A.E., Berendsen H.J. GROMACS: fast, flexible, and free. J Comput Chem 2005, 26:1701-1718.
112. Hubbard S.J., Thornton J.M. 'NACCESS', Computer Program Department of Biochemistry and Molecular Biology 1993, University College, London.
113. DeLano WLT. The PyMOL Molecular Graphics System DeLano Scientific, San Carlos, CA, USA; 2002. http://wwwpymolorg/.
114. Wu S., Zhang Y. LOMETS: a local meta-threading-server for protein structure prediction. Nucleic Acids Res 2007, 35:3375-3382.
115. Wu S., Zhang Y., Muste R. Improving protein sequence profile-profile alignments by using multiple sources of structure information. Proteins 2008, 72:547-556.
116. Gao X., Bu D., Xu J., Li M. Improving consensus contact prediction via server correlation reduction. BMC Struct Biol 2009, 9:28.
117. Guo J.T., Ellrott K., Chung W.J., Xu D., Passovets S., Xu Y. PROSPECT-PSPP: an automatic computational pipeline for protein structure prediction. Nucleic Acids Res 2004, 32:W522-W525.
118. Zhou H., Skolnick J. Protein structure prediction by pro-Sp3-TASSER. Biophys J 2009, 96:2119-2127.
119. Soding J. Protein homology detection by HMM-HMM comparison. Bioinformatics 2005, 21:951-960.
120. Zhou H., Zhou Y. SPARKS 2 and SP3 servers in CASP6. Proteins 2005, 61(Suppl. 7):152-156.
121. Shi J., Blundell T.L., Mizuguchi K. FUGUE: sequence-structure homology recognition using environment-specific substitution tables and structure-dependent gap penalties. J Mol Biol 2001, 310:243-257.
122. Kelley L.A., Sternberg M.J. Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc 2009, 4:363-371.
123. Jaakola V.P., Griffith M.T., Hanson M.A., Cherezov V., Chien E.Y., Lane J.R., et al. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 2008, 322:1211-1217.
124. Hoffman G.R., Rahl P.B., Collins R.N., Cerione R.A. Conserved structural motifs in intracellular trafficking pathways: structure of the gammaCOP appendage domain. Mol Cell 2003, 12:615-625.
125. Dias F.M., Vincent F., Pell G., Prates J.A., Centeno M.S., Tailford L.E., et al. Insights into the molecular determinants of substrate specificity in glycoside hydrolase family 5 revealed by the crystal structure and kinetics of Cellvibrio mixtus mannosidase 5A. J Biol Chem 2004, 279:25517-25526.
126. Okada T., Sugihara M., Bondar A.N., Elstner M., Entel P., Buss V. The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. J Mol Biol 2004, 342:571-583.
127. Berendsen H.J.C., van der Spoel D., van Drunen R. GROMACS: a message-passing parallel molecular dynamics implementation. Comp Phys Comm 1995, 91:43-56.
128. de Brevern A.G. New assessment of a structural alphabet. In Silico Biol 2005, 5:283-289.
129. de Brevern A.G., Etchebest C., Benros C., Hazout S. " Pinning strategy": a novel approach for predicting the backbone structure in terms of protein blocks from sequence. J Biosci 2007, 32:51-70.
130. de Brevern A.G., Benros C., Gautier R., Valadie H., Hazout S., Etchebest C. Local backbone structure prediction of proteins. In Silico Biol 2004, 4:381-386.
131. Hollup S.M., Salensminde G., Reuter N. WEBnm@: a web application for normal mode analyses of proteins. BMC Bioinformatics 2005, 6:52.
132. Lindahl E., Azuara C., Koehl P., Delarue M. NOMAD-Ref: visualization, deformation and refinement of macromolecular structures based on all-atom normal mode analysis. Nucleic Acids Res 2006, 34:W52-W56.
133. Suhre K., Sanejouand Y.H. ElNemo: a normal mode web server for protein movement analysis and the generation of templates for molecular replacement. Nucleic Acids Res 2004, 32:W610-W614.
134. Suhre K., Sanejouand Y.H. On the potential of normal-mode analysis for solving difficult molecular-replacement problems. Acta Crystallogr D Biol Crystallogr 2004, 60:796-799.
135. Rocchia W., Alexov B., Honig B. Extending the applicability of the nonlinear Poisson-Boltzmann equation: multiple dielectric constants and multivalent ions. J Phys Chem B 2001, 105:6507-6514.
136. Crump M.P., Gong J.H., Loetscher P., Rajarathnam K., Amara A., Arenzana-Seisdedos F., et al. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J 1997, 16:6996-7007.
137. Baysal C., Atilgan A.R. Elucidating the structural mechanisms for biological activity of the chemokine family. Proteins 2001, 43:150-160.
138. Fernandez-Recio J., Totrov M., Abagyan R. ICM-DISCO docking by global energy optimization with fully flexible side-chains. Proteins 2003, 52:113-117.
139. ICM. http://www.molsoft.com/.
140. Comeau S.R., Gatchell D.W., Vajda S., Camacho C.J. ClusPro: a fully automated algorithm for protein-protein docking. Nucleic Acids Res 2004, 32:W96-W99.
141. Comeau S.R., Gatchell D.W., Vajda S., Camacho C.J. ClusPro: an automated docking and discrimination method for the prediction of protein complexes. Bioinformatics 2004, 20:45-50.
142. Hamers-Casterman C., Atarhouch T., Muyldermans S., Robinson G., Hamers C., Songa E.B., et al. Naturally occurring antibodies devoid of light chains. Nature 1993, 363:446-448.
143. Muyldermans S., Baral T.N., Retamozzo V.C., De Baetselier P., De Genst E., Kinne J., et al. Camelid immunoglobulins and nanobody technology. Vet Immunol Immunopathol 2009, 128:178-183.
144. Baral T.N., Magez S., Stijlemans B., Conrath K., Vanhollebeke B., Pays E., et al. Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor. Nat Med 2006, 12:580-584.
145. Abderrazek R.B., Hmila I., Vincke C., Benlasfar Z., Pellis M., Dabbek H., et al. Identification of potent nanobodies to neutralize the most poisonous polypeptide from scorpion venom. Biochem J 2009, 424:263-272.
146. Dumoulin M., Last A.M., Desmyter A., Decanniere K., Canet D., Larsson G., et al. A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme. Nature 2003, 424:783-788.
147. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997, 25:3389-3402.
148. De Genst E., Handelberg F., Van Meirhaeghe A., Vynck S., Loris R., Wyns L., et al. Chemical basis for the affinity maturation of a camel single domain antibody. J Biol Chem 2004, 279:53593-53601.
149. Wootton J.C., Federhen S. Analysis of compositionally biased regions in sequence databases. Methods Enzymol 1996, 266:554-571.
150. Decanniere K., Transue T.R., Desmyter A., Maes D., Muyldermans S., Wyns L. Degenerate interfaces in antigen-antibody complexes. J Mol Biol 2001, 313:473-478.
151. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22:4673-4680.
152. Laskowski R.A., MacArthur M.W., Moss D.S., Thornton J.M. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Cryst 1993, 26:283-291.
153. Valadié H., Lacapere J.J., Sanejouand Y.H., Etchebest C. Dynamical properties of the MscL of Escherichia coli: a normal mode analysis. J Mol Biol 2003 Sep 19, 332(3):657-674. PMID: 12963374.